ENVIRONMENTAL MODIFIERS OF SEVERITY IN CHILDREN WITH SICKLE CELL DISEASE: A FEASIBILITY PILOT STUDY

EHA Library, John Strouse, 359077

REPORTING LANGUAGE IN HAEMATOLOGICAL MALIGNANCIES

EHA Library, Sophie Ralston, 359214

BEST PRACTICES ON EMPOWERING AND INVOLVING PATIENTS LIVING WITH HEMATOLOGICAL MALIGNANCIES ON THE DEVELOPMENT OF NOVEL PATIENT-REPORTED OUTCOME MEASURES

EHA Library, Nikolaos Vrontaras, 359213

PREDIGA, EDUCATIONAL AND DIAGNOSIS PROJECT IN ACID SPHINGOMYELINASE DEFICIENCY DISEASE (ASMD) AND GAUCHER DISEASE (GD): RESULTS TO THE OBJECTIVE ACHIEVED OF 200 PATIENTS ANALYZED.

EHA Library, Jesus Villarrubia, 359212

QUALITY OF LIFE AND TREATMENT SATISFACTION AMONG PATIENTS UNDER LONG-TERM ANTICOAGULANT THERAPY WITH VITAMIN K ANTAGONISTS

EHA Library, AGORITSA VARAKLIOTI, 359211

HEALTHCARE RESOURCE UTILIZATION OF ADULT PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A REAL WORLD STUDY USING US VETERANS HEALTH ADMINISTRATION DATA

EHA Library, Erin Zagadailov, 359210

SIGNIFICANT INCREASE IN NEWLY DIAGNOSED HEMATOLOGICAL MALIGNANCIES FOLLOWING LOCKDOWN EASE IN CROATIA

EHA Library, Marin Simunic, 359209

EFFECTS OF CHRONIC DISEASE LOCUS INTERVENTION MODEL ON QUALITY OF LIFE AND STRESS IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Cheng ZHANG, 359208

THE RELATIONSHIP BETWEEN SYMPTOM CLUSTERS AND QUALITY OF LIFE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION DURING EARLY TRANSPLANT: A LONGITUDINAL STUDY

EHA Library, Lei Gao, 359207

EFFECTS OF TARGETED NURSING INTERVENTIONS ON CANCER-INDUCED FATIGUE AND MENTAL HEALTH IN CHEMOTHERAPY PATIENTS WITH LEUKEMIA

EHA Library, Dahua Lan, 359206

THE IMPACT OF ACUTE HEPATIC PORPHYRIA ON MENTAL HEALTH: RESULTS FROM THE PORPHYRIA WORLDWIDE PATIENT EXPERIENCE RESEARCH (POWER) STUDY

EHA Library, Danielle Nance, 359205

HEALTHCARE RESOURCE UTILIZATION AND COSTS OFF THERAPY WITH FIXED-DURATION VENETOCLAX AMONG CLL PATIENTS

EHA Library, John Allan, 359204

CONSOLIDATION OF ERN-EUROBLOODNET: THE EUROPEAN REFERENCE NETWORK ON RARE HEMATOLOGICAL DISEASES FIRST 5 YEARS OF IMPLEMENTATION

EHA Library, Maria Del Mar Mañú Pereira, 359203

ANXIETY AT THE HEMATOLOGIST

EHA Library, Snezana Trojan, 359202

SAFETY AND EFFICACY OF HYPODERMOCLYSIS IN PATIENTS WITH HEMATOLOGICAL CANCERS

EHA Library, Ana Kodru, 359201

LESSONS LEARNED FROM THE MYPAL DIGITAL HEALTH INTERVENTION: CAPITALIZING ON THE PATIENT REPORTED OUTCOMES (PRO) PARADIGM TOWARDS A PARTICIPATORY HEALTHCARE FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

EHA Library, Christina Karamanidou, 359200

THE PATIENT'S PERSPECTIVE ON CLNICAL TRIALS: RESULTS FROM A REGIONAL SURVEY IN HAEMATOLOGICAL CENTERS IN ANTWERP

EHA Library, Bert Heyrman, 359199

GLOBAL REPRESENTATION AMONG JOURNAL EDITORS IN HEMATOLOGY: ARE WE DIVERSE, EQUITABLE, AND INCLUSIVE?

EHA Library, Andrés Gomez De León, 359198

COMPARISON OF PRESCRIBING ERRORS WITH DIRECT ORAL ANTICOAGULANTS BETWEEN PAPER BASED AND ELECTRONIC BASED PRESCRIBING METHODS AT A REGIONAL BASE HOSPITAL IN NSW, AUSTRALIA

EHA Library, David Glendinning, 359197

ADAPTING PATIENT EDUCATIONAL APPROACHES IN PYRUVATE KINASE DEFICIENCY: EUROPE AND NORTH AMERICA FINDINGS FROM THE AAC PATIENT AND CAREGIVER SURVEY

EHA Library, Wilma Barcellini, 359196

RESILIENCE IN PATIENTS WITH LYMPHOID MALIGNANCIES: THE REPLY STUDY.

EHA Library, Gimena dos Santos, 359195

EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT

EHA Library, Mehran Karimi, 359082

NECESSITY FOR A ROBUST INFRASTRUCTURE FOR TREATING ALLIED COMPLICATIONS OF AGEING HAEMOGLOBINOPATHY POPULATION IN MIDDLE INCOME COUNTRIES

EHA Library, Tanzeel Imran, 359081

PRECISION MEDICINE IN THALASSEMIA: 30-YEAR EXPERIENCE AT SINGLE INSTITUTE FROM SAUDI ARABIA

EHA Library, Soad Al Jaouni, 359080

HEALTH-RELATED QUALITY OF LIFE OVER TIME IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE ADMITTED FOR VASO-OCCLUSIVE CRISIS.

EHA Library, Caroline Vuong, 359079

THE ROLE OF COMPLEMENT IN THE IMMUNE RESPONSE OF SICKLE CELL DISEASE PATIENTS AFER COVID-19 VACCINATION

EHA Library, Christos Varelas, 359078

COST OF ILLNESS, EPIDEMIOLOGY AND HEALTHCARE RESOURCE UTILIZATION FOR SICKLE CELL DISEASE IN THE GULF "CESGU"

EHA Library, Dina Soliman, 359076

IMPACT OF COVID-19 PANDEMIC ON PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM THE REAL WORLD ASSESSMENT SURVEY FOR SICKLE CELL DISEASE IN SAUDI (ROARS)

EHA Library, Hatoon Ezzat, 359075

THE PROTECTIVE EFFECT OF THE SPLEEN IN SICKLE CELL PATIENTS. A COMPARATIVE STUDY BETWEEN PATIENTS WITH ASPLENIA AND HYPERSPLENISM.

EHA Library, Sari Peretz, 359074

A SYSTEMATIC LITERATURE REVIEW DESCRIBING PROTECTIVE EFFECTS OF HBF IN SICKLE CELL DISEASE OUTCOMES

EHA Library, Olga Mitelman, 359073

MORTALITY IN PATIENTS WITH HEMOGLOBINOPATHIES AND (SARS-COV-2) COVID-19 INFECTION: SAUDI ARABIA EXPERIENCE

EHA Library, Hatoon Ezzat, 359072

A REAL-WORLD EXPERIENCE WITH HEALTHCARE RESOURCE UTILIZATION PATTERNS AND RELATED COSTS IN PATIENTS WITH SICKLE CELL DISEASE IN NORTH LEBANON

EHA Library, Adlette Inati, 359071

ASSESSMENT OF CYSTATIN C IN PEDIATRIC SICKLE CELL DISEASE ANDB-THALASSEMIA AS A MARKER OF SUBCLINICAL CARDIOVASCULARDYSFUNCTION: A CASE-CONTROL STUDY

EHA Library, Diana Hanna, 359070

SICKLE CELL DISEASE IS A RISK FACTOR FOR THE PROGRESSION AND PROGNOSIS OF COVID-19

EHA Library, Vikas Goyal, 359069

Abstract Book 2022

EHA Library, Faculty / Presenters, 400188

Current developments in CD123-positive haematological malignancies

EHA Library, Stemline, 372499

How I Treat: Chimeric antigen receptor T(CAR-T) in Clinical Practice for lymphomas and leukemias

EHA Library, Novartis, 372498

The human impact of chronic myeloid leukemia (CML) after 2 TKIs: What does the data mean for patients and the clinical practice?

EHA Library, Novartis, 372497

Is Complete Response Enough? An Expert Look Towards the Future of Higher-Risk Myelodysplastic syndrome (MDS) Treatment

EHA Library, Novartis, 372496

Unmet needs and future possibilities for paroxysmal nocturnal hemoglobinuria (PNH): hear the patient perspective and expert opinions

EHA Library, Novartis, 372495

Exploring unmet needs and therapeutic targets for immune thrombocytopenia and warm autoimmune hemolytic anemia

EHA Library, Novartis, 372494

F. Hoffmann-La Roche Ltd.

EHA Library, F. Hoffmann-La Roche Ltd., 372493

Immunotherapy: evolution or revolution in the cure of multiple myeloma

EHA Library, Janssen, 372492

Immunotherapies: Rising to the challenge of relapsed/refractory multiple myeloma

EHA Library, Janssen, 372491

Minimal residual disease (MRD): the big question mark in Chronic Lymphocytic Leukemia (CLL)?

EHA Library, Janssen, 372490

Optimizing treatment selection and sequencing for patients with multiple myeloma: A precision medicine approach

EHA Library, Janssen, 372489

Refining care and improving outcomes in immune thrombocytopenia (ITP) patients

EHA Library, Grifols, 372488

T-cell Engaging Bispecific Antibodies: A New Era in the Management of Relapsed/Refractory Follicular Lymphoma

EHA Library, F. Hoffmann-La Roche Ltd., 372487

Advancing C5 Inhibitor Therapy: Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease

EHA Library, F. Hoffmann-La Roche Ltd., 372486

Advancing CAR T cell therapies in B-cell malignancies

EHA Library, BMS, 372485

Advancements in the treatment of B-cell malignancies

EHA Library, BMS, 372484

Myelodysplastic syndrome (MDS) and Acute Myeloid Leukemia (AML): from Trials to Practice

EHA Library, BMS, 372483

Recent advancements in immune therapies for multiple myeloma

EHA Library, BMS, 372482

When to Consider Re-evaluation of Therapy for Myelofibrosis: Understanding and Managing Treatment Failure

EHA Library, BMS, 372481

Expert Insights into β-thalassemia Management

EHA Library, BMS, 372480

Bruton's tyrosine kinase (BTK) inhibition in B-Cell Malignancies – A critical target for effective and safe treatment

EHA Library, BeiGene, 372479

Biosimilars for Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment: What Rare Disease Experts Should Know

EHA Library, Amgen, 372477

Abstract Book 2021

EHA Library, Faculty / Presenters, 400187

OVERALL SURVIVAL RESULTS WITH DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE VERSUS LENALIDOMIDE AND DEXAMETHASONE IN TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: PHASE 3 MAIA STUDY

EHA Library, Thierry Facon, 330171

FIXED-DURATION IBRUTINIB AND VENETOCLAX (I+V) VERSUS CHLORAMBUCIL PLUS OBINUTUZUMAB (CLB+O) FOR FIRST-LINE (1L) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): PRIMARY ANALYSIS OF THE PHASE 3 GLOW STUDY

EHA Library, Arnon P. Kater, 330172

SAFETY AND EFFICACY OF CD37-TARGETING NARATUXIMAB EMTANSINE PLUS RITUXIMAB IN DIFFUSE LARGE B-CELL LYMPHOMA AND OTHER NON-HODGKIN’S B-CELL LYMPHOMAS - A PHASE 2 STUDY

EHA Library, Moshe Yair Levy, 330173

A COMPARISON OF CLINICAL OUTCOMES FROM ZUMA-5 (AXICABTAGENE CILOLEUCEL) AND THE INTERNATIONAL SCHOLAR-5 EXTERNAL CONTROL COHORT IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL)

EHA Library, John Gribben, 330174

FIRST INTERIM ANALYSIS OF ALPINE STUDY: RESULTS OF A PHASE 3 RANDOMIZED STUDY OF ZANUBRUTINIB VS IBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA

EHA Library, Peter Hillmen, 330170

Monoclonal Antibodies in Multiple Myeloma: New Trials and Combinations

EHA Library, F Schjesvold, 337346

Case 5: Holmes and Watson’s involvement is only skin-deep

EHA Library, A Pession, 337345

Case 2: For Sherlock Holmes it’s never too late

EHA Library, A Pession, 337344

Case 1: A case of double trouble

EHA Library, H Rosenbaum, 337343

Q&A and closing remarks

EHA Library, B Inusa, 337368

Case 3: It’s simple Watson – persistence pays off!

EHA Library, M Machaczka, 337341

Live Q&A and conclusions

EHA Library, M Machaczka, 337340

Introduction

EHA Library, M Machaczka, 337339

Case discussion: How can we improve the management of relapsed/refractory follicular lymphoma?

EHA Library, T Vassilakopoulos, 337338

Welcome and Introductions

EHA Library, G Jackson, 337347

Post-session Survey

EHA Library, G Jackson, 337348

Case-Based Discussion: Treatment Across the Spectrum of Relapsed/Refractory Disease

EHA Library, G Jackson, 337349

The Monoclonal Antibody Landscape in Relapsed/Refractory Multiple Myeloma

EHA Library, E Ocio, 337350

Audience Q & A

EHA Library, C Bygrave, 337351

IMCD IS NOT AN INDOLENT DISEASE: REAL-WORLD EVIDENCE SUGGESTS WE MUST ACT IMMEDIATELY

EHA Library, M Streetly, 337352

Welcome & Introductions

EHA Library, C Buske, 337353

Panel Discussion and Audience Q & A

EHA Library, C Buske, 337354

WM – SoC and Role of BTK inhibitors now and in future

EHA Library, C Buske, 337355

Rationale for Targeting TLR/BCR in Indolent Lymphomas – Role of BTK inhibition as Treatment Option for WM and MZL

EHA Library, S Treon, 337356

MZL – SoC and Role of BTK inhibitors now and in future

EHA Library, A Tedeschi, 337357

WM and MZL – disease, diagnosis, role of TLR/BCR pathway

EHA Library, S D’Sa, 337358

Serial Monitoring of Measurable Residual Disease (MRD) by NGS in the Context of Effective Chronic Lymphocytic Leukemia (CLL) Therapy.

EHA Library, O Al-Sawaf, 337367

Evidence from clinical trials for the role of fostamatinib in ITP

EHA Library, W Ghanima, 337359

Other applications of Syk inhibition: its role in wAIHA and Covid.

EHA Library, Q Hill, 337360

Welcome & Introduction

EHA Library, N Cooper, 337361

Panel discussion / Q&A

EHA Library, N Cooper, 337362

Very low incidence of thrombosis in patients with ITP treated with fostamatinib; a pointer towards a novel antithrombotic pathway

EHA Library, P Nicolson, 337363

Assessment of Undetectable Minimal Residual Disease (MRD) and Time-Limited therapy in Chronic Lymphocytic Leukemia (CLL) Routine Clinical Practice.

EHA Library, J Pagel, 337364

Panel Discussion

EHA Library, J Pagel, 337365

Undetectable Peripheral Blood Measurable Residual Disease (MRD), and relevance of ctDNA, for the Management of Chronic Lymphocytic Leukemia (CLL) Patients.

EHA Library, P Blombery, 337366

Managing patients with hemolytic anemia and comorbidities: Patient cases

EHA Library, C Minniti, 337374

Evidence-based mini-review: The role of hemolysis and anemia in the progression of SCD

EHA Library, E Vichinsky, 337373

Q&A

EHA Library, B Inusa, 337372

Fundamentals of sickle cell disease: Understanding the pathophysiology and course of the disease

EHA Library, B Inusa, 337371

Introduction

EHA Library, B Inusa, 337370

Q&A

EHA Library, B Inusa, 337369

Case 4: Solving the case of the White Storm

EHA Library, H Rosenbaum, 337342